Pharmaceuticals
EPO revokes Amgen antibody patent amid ongoing battle with Sanofi
As part of their global dispute over cholesterol-lowering medication, Amgen has lost a divisional patent following a challenge by Sanofi. The patent, which was revoked by the EPO Opposition Division f
...
22 March 2023 by Amy Sandys